Sanofi plans to spin off its consumer-healthcare unit into a publicly listed entity, making it the latest pharmaceutical giant to sharpen its focus on prescription medicines by offloading adjacent businesses.
Sanofi plans to spin off its consumer-healthcare unit into a publicly listed entity, making it the latest pharmaceutical giant to sharpen its focus on prescription medicines by offloading adjacent businesses.